What is considered a high Framingham risk score?

Individuals with low risk have 10% or less CHD risk at 10 years, with intermediate risk 10-20%, and with high risk 20% or more.

What are the criticisms of the Framingham Heart Study?

Some four decades later, there is mounting criticism of the Framingham risk score. First, because it does not predict cardiovascular risk ‘accurately’ enough – when applied to different populations, the score tends to overestimate risk in low-risk populations and underestimate risk in high-risk populations.

What is a coronary heart disease risk equivalent?

What does CAD risk equivalent mean? According to the above panel, ATP III, “CAD risk equivalent” is the risk of developing a major coronary event (MI + coronary death) over 10 years >20%.

What is a high Qrisk score?

QRISK is an algorithm for predicting cardiovascular risk. It estimates the risk of a person developing cardiovascular disease (CVD) over the next 10 years and can be applied to those aged between 35 and 74 years. Those with a score of 20 per cent or more are considered to be at high risk of developing CVD.

Who did the Framingham study examine?

The Framingham study was designed to track health information on men and women who initially did not show signs of heart disease. The original cohort (study group) included two-thirds of the adult population (more than 5,200 residents) of Framingham, with ages ranging from 30 to 62 years.

What is the purpose of the Framingham Risk Score?

Framingham Risk Score. The Framingham Risk Score is a gender-specific algorithm used to estimate the 10-year cardiovascular risk of an individual.

When to use the hard Framingham outcome model?

There are several distinct Framingham risk models. MDCalc uses the ‘Hard’ coronary Framingham outcomes model, which is intended for use in non-diabetic patients age 30-79 years with no prior history of coronary heart disease or intermittent claudication, as it is the most widely applicable…

When to use the Framingham model for mdcalc?

MDCalc uses the ‘Hard’ coronary Framingham outcomes model, which is intended for use in non-diabetic patients age 30-79 years with no prior history of coronary heart disease or intermittent claudication, as it is the most widely applicable to patients without previous cardiac events.